Detalhe da pesquisa
1.
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.
Br J Haematol
; 204(2): 525-533, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905734
2.
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study.
Cancer Immunol Immunother
; 72(4): 827-840, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36083313
3.
Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary disease.
Am J Hematol
; 97(6): 731-739, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35253928
4.
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.
Proc Natl Acad Sci U S A
; 116(17): 8463-8470, 2019 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962374
5.
Therapeutic potential of tolerogenic dendritic cells in IBD: from animal models to clinical application.
Clin Dev Immunol
; 2013: 789814, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24319468
6.
Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer.
Cells
; 9(1)2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31947623
7.
Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.
Front Immunol
; 9: 1169, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29904379
8.
Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma.
Front Oncol
; 8: 127, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29755954
9.
Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma.
Front Oncol
; 8: 201, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29897054
10.
Up-regulation of EP2 and EP3 receptors in human tolerogenic dendritic cells boosts the immunosuppressive activity of PGE2.
J Leukoc Biol
; 102(3): 881-895, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28630103
11.
Nanoencapsulated budesonide in self-stratified polyurethane-polyurea nanoparticles is highly effective in inducing human tolerogenic dendritic cells.
Int J Pharm
; 511(2): 785-93, 2016 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27477102
12.
New insights into the phenotype of human dendritic cell populations.
Clin Transl Immunology
; 5(1): e61, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26900474
13.
In vivo tracking and immunological properties of pulsed porcine monocyte-derived dendritic cells.
Mol Immunol
; 63(2): 343-54, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25282042
14.
MERTK as negative regulator of human T cell activation.
J Leukoc Biol
; 97(4): 751-60, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25624460
15.
Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn's Disease: A Phase I Study.
J Crohns Colitis
; 9(12): 1071-8, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26303633
16.
Priming by chemokines restricts lateral mobility of the adhesion receptor LFA-1 and restores adhesion to ICAM-1 nano-aggregates on human mature dendritic cells.
PLoS One
; 9(6): e99589, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24945611
17.
Gram-negative enterobacteria induce tolerogenic maturation in dexamethasone conditioned dendritic cells.
PLoS One
; 7(12): e52456, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23300676
18.
Analysis of HLDA9 mAbs on plasmacytoid dendritic cells.
Immunol Lett
; 134(2): 167-73, 2011 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20933012